Literatur
- 1
Harrison S A, Torgerson S, Hayashi P H.
The natural history of nonalcoholic fatty liver disease: a clinical histopathological
study.
Am J Gastroenterol.
2003;
98
2042-2047
- 2
Adams L A. et al .
The histological course of nonalcoholic fatty liver disease: a longitudinal study
of 103 patients with sequential liver biopsies.
J Hepatol.
2005;
42
132-138
- 3
Hui J M. et al .
Long-term outcomes of cirrhosis in nonalcoholic steatohepatitis compared with hepatitis
C.
Hepatology.
2003;
38
420-427
- 4
Powell E E. et al .
The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two
patients for up to 21 years.
Hepatology.
1990;
11
74-80
- 5
Czaja A J.
Recurrence of nonalcoholic steatohepatitis after liver transplantation.
Liver Transpl Surg.
1997;
3
185-186
- 6
Kim W R. et al .
Recurrence of nonalcoholic steatohepatitis following liver transplantation.
Transplantation.
1996;
62
1802-1805
- 7
Molloy R M, Komorowski R, Varma R R.
Recurrent nonalcoholic steatohepatitis and cirrhosis after liver transplantation.
Liver Transpl Surg.
1997;
3
177-178
- 8
Contos M J. et al .
Development of nonalcoholic fatty liver disease after orthotopic liver transplantation
for cryptogenic cirrhosis.
Liver Transpl.
2001;
7
363-373
- 9
Garcia R F. et al .
Recurrent and de novo non-alcoholic steatohepatitis following orthotopic liver transplantation.
Arq Gastroenterol.
2001;
38
247-253
- 10
Alba L M, Lindor K.
Review article: Non-alcoholic fatty liver disease.
Aliment Pharmacol Ther.
2003;
17
977-986
- 11
Perez Aguilar F. et al .
Non-alcoholic statohepatitis: physiopathological, clinical and therapeutic implications.
Rev Esp Enferm Dig.
2004;
96
628-639 [440 – 448]
- 12
Charlton M. et al .
Frequency of nonalcoholic steatohepatitis as a cause of advanced liver disease.
Liver Transpl.
2001;
7
608-614
- 13
Farrell G C, Larter C Z.
Nonalcoholic fatty liver disease: from steatosis to cirrhosis.
Hepatology.
2006;
43 (2 Suppl 1)
99-112
- 14
Caldwell S H. et al .
Cryptogenic cirrhosis: clinical characterization and risk factors for underlying disease.
Hepatology.
1999;
29
664-669
- 15
Saunders J B. et al .
A 20-year prospective study of cirrhosis.
Br Med J (Clin Res Ed).
1981;
282
263-266
- 16
Ayata G. et al .
Cryptogenic cirrhosis: clinicopathologic findings at and after liver transplantation.
Hum Pathol.
2002;
33
1098-1104
- 17
Duclos-Vallee J C. et al .
Could post-liver transplantation course be helpful for the diagnosis of so called
cryptogenic cirrhosis?.
Clin Transplant.
2005;
19
591-599
- 18
Berg T. et al .
Distinct enzyme profiles in patients with cryptogenic cirrhosis reflect heterogeneous
causes with different outcomes after liver transplantation (OLT): a long-term documentation
before and after OLT.
Transplantation.
2002;
74
792-798
- 19
Angulo P. et al .
Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis.
Hepatology.
1999;
30
1356-1362
- 20
Angelico R.
Drugs improving insulin resistance for non-alcoholic fatty liver disease and/or non-alcoholic
steatohepatitis.
Cochrane Database.
2007;
- 21
Loomba R. et al .
Clinical trial: Pilot study of metformin for the treatment of nonalcoholic steatohepatitis.
Aliment Pharmacol Ther.
2008;
10
9
Prof. Dr. med. Arndt Hartmann
Universitätsklinikum Erlangen
Institut für Pathologie
Universitätsstraße 21 – 23
91054 Erlangen
eMail: Arndt.Hartmann@uk-erlangen.de
